Elisigen develops gene therapy products for neurological diseases, utilizing adeno-associated virus gene therapy to improve the quality of life for patients suffering from neurodegenerative disorders and other rare diseases
Elisigen develops gene therapy products for neurological diseases, utilizing adeno-associated virus gene therapy to improve the quality of life for patients suffering from neurodegenerative disorders and other rare diseases.
The top three firms on F4's Biotech & Life Sciences investor list.